{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:38:04Z","timestamp":1786981084224,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s10741-005-2349-x","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T13:35:03Z","timestamp":1118324103000},"page":"53-62","source":"Crossref","is-referenced-by-count":24,"title":["Effect of Aldosterone and MR Blockade on the Brain and the Kidney"],"prefix":"10.1007","volume":"10","author":[{"suffix":"Jr.","given":"Charles T.","family":"Stier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen N.","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2349_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","volume":"13","author":"EP Gomez-Sanchez","year":"2004","unstructured":"Gomez-Sanchez EP. Brain mineralocorticoid receptors: Orchestrators of hypertension and end-organ disease. Curr Opinion Nephrol Hypertens 2004;13:191\u2013196.","journal-title":"Curr Opinion Nephrol Hypertens"},{"key":"2349_CR2","first-page":"E657","volume":"269","author":"M Young","year":"1995","unstructured":"Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995;269:E657\u2013E662.","journal-title":"Am J Physiol"},{"key":"2349_CR3","doi-asserted-by":"crossref","first-page":"H2241","DOI":"10.1152\/ajpheart.2001.281.5.H2241","volume":"281","author":"J Francis","year":"2001","unstructured":"Francis J, Weiss RM, Wei S-G, et al. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Circ Physiol 2001;281:H2241\u2013H2251.","journal-title":"Am J Physiol Circ Physiol"},{"key":"2349_CR4","first-page":"F781","volume":"264","author":"KM Todd-Turla","year":"1993","unstructured":"Todd-Turla KM, Schnermann J, Fejes-Toth G, et al. Distribution of mineralocorticoid and glucocorticoid mRNA along the nephron. Am J Physiol 1993;264:F781\u2013 F791.","journal-title":"Am J Physiol"},{"key":"2349_CR5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.RES.0000106135.02935.E1","volume":"93","author":"TR Uhrenholt","year":"2003","unstructured":"Uhrenholt TR, Schjerning J, Hansen PB, et al. Rapid inhibition of vasocontriction in renal afferent arterioles by aldosterone. Circ Res 2003;93:1258\u20131266.","journal-title":"Circ Res"},{"key":"2349_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1523-1755.2003.00731.x","volume":"63","author":"ME Ullian","year":"2003","unstructured":"Ullian ME, Gantt BJ, Ford AK, Tholanikunnel BG, Spicer EK, Fitzgibbon WR. Potential importance of glomerular citrate synthase activity in remnant nephropathy. Kidney Int 2003;63:156\u2013164.","journal-title":"Kidney Int"},{"key":"2349_CR7","first-page":"E452","volume":"246","author":"D Marver","year":"1984","unstructured":"Marver D. Influence of adrenalectomy and steroid replacement on heart citrate synthase levels. Am J Physiol 1984;246:E452\u2013E457.","journal-title":"Am J Physiol"},{"key":"2349_CR8","first-page":"R825","volume":"268","author":"DB Young","year":"1995","unstructured":"Young DB, Lin H, McCabe RD. Potassium\u2019s cardiovascular protective mechanisms. Am J Physiol 1995;268:R825\u2013R837.","journal-title":"Am J Physiol"},{"key":"2349_CR9","first-page":"H1955","volume":"274","author":"BC Yang","year":"1998","unstructured":"Yang BC, Li DY, Weng YF, Lynch J, Wingo CS, Mehta JL. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. Am J Physiol 1998;274:H1955\u2013H1961.","journal-title":"Am J Physiol"},{"key":"2349_CR10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.101.14.1722","volume":"101","author":"MJ Somers","year":"2000","unstructured":"Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000;101:1722\u20131728.","journal-title":"Circulation"},{"key":"2349_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"2349_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"2349_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00060793-199806000-00011","volume":"5","author":"CT Stier Jr","year":"1998","unstructured":"Stier CT Jr, Chander PN, Zuckerman A, Rocha R. Nonepithelial effects of aldosterone. Current Opinion in Endocrinology and Diabetes 1998;5:211\u2013216.","journal-title":"Current Opinion in Endocrinology and Diabetes"},{"key":"2349_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00045415-200203000-00008","volume":"10","author":"CT Stier Jr","year":"2002","unstructured":"Stier CT Jr, Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiology in Review 2002;10:97\u2013107.","journal-title":"Cardiology in Review"},{"key":"2349_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","volume":"286","author":"HR Brunner","year":"1972","unstructured":"Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441\u2013449.","journal-title":"N Engl J Med"},{"key":"2349_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","volume":"33","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Uzu T, Fujii T, et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999;33:261\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"2349_CR17","first-page":"1801","volume":"13","author":"J-M Halimi","year":"1995","unstructured":"Halimi J-M, Mimram A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995;13:1801\u20131802.","journal-title":"J Hypertens"},{"key":"2349_CR18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.RES.36.2.300","volume":"36","author":"H Gavras","year":"1975","unstructured":"Gavras H, Brunner HR, Laragh JH, et al. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Role of renin and sodium in vascular changes. Circ Res 1975;36:300\u2013309.","journal-title":"Circ Res"},{"key":"2349_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","volume":"107","author":"JW Conn","year":"1964","unstructured":"Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surgery 1964;107:159\u2013172.","journal-title":"Am J Surgery"},{"key":"2349_CR20","first-page":"401","volume":"45","author":"DG Beevers","year":"1976","unstructured":"Beevers DG, Brown JJ, Ferriss JB et al. Renal abnormalities and vascular complications in primary aldosteronism. Evidence on tertiary hyperaldosteronism. Q J Med 1976;45:401\u2013410.","journal-title":"Q J Med"},{"key":"2349_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0090-4295(96)00166-5","volume":"48","author":"RW Grady","year":"1996","unstructured":"Grady RW, Kaylor WM, Lee J-C, Bravo EL, Gephardt GN, Novick AC. Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma. Urology 1996;48:369\u2013372.","journal-title":"Urology"},{"key":"2349_CR22","first-page":"88","volume":"49","author":"H Selye","year":"1943","unstructured":"Selye H, Hall CE, Rowley EM. Malignant hypertension produced by treatment with desoxycorticosterone acetate and sodium chloride. Can Med Assoc J 1943;49:88\u201392.","journal-title":"Can Med Assoc J"},{"key":"2349_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.RES.4.5.527","volume":"4","author":"A Robert","year":"1956","unstructured":"Robert A. Complete prevention of cerebral accidents in malignant hypertension. Circ Res 1956;4:527\u2013532.","journal-title":"Circ Res"},{"key":"2349_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 1998;31: 445\u2013450.","journal-title":"Hypertension"},{"key":"2349_CR25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajh\/4.8.680","volume":"4","author":"CT Stier Jr","year":"1991","unstructured":"Stier CT Jr, Chander PN, Gutstein WH, Levine S, Itskovitz HD. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 1991;4:680\u2013687.","journal-title":"Am J Hypertens"},{"issue":"supp 3","key":"2349_CR26","first-page":"S37","volume":"11","author":"CT Stier Jr","year":"1993","unstructured":"Stier CT Jr, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertension 1993;11(supp 3):S37\u2013S42.","journal-title":"J Hypertension"},{"key":"2349_CR27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"R Rocha","year":"1998","unstructured":"Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998;31:451\u2013458.","journal-title":"Hypertension"},{"key":"2349_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","volume":"12","author":"R Rocha","year":"2001","unstructured":"Rocha R, Stier CT Jr. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001;12:308\u2013314.","journal-title":"Trends Endocrinol Metab"},{"key":"2349_CR29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.STR.28.9.1821","volume":"28","author":"AB MacLeod","year":"1997","unstructured":"MacLeod AB, Vasdev S, Smeda JS. The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats. Stroke 1997;28:1821\u20131829.","journal-title":"Stroke"},{"key":"2349_CR30","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","volume":"281","author":"AM Dorrance","year":"2001","unstructured":"Dorrance AM, Osborn HL, Grekin R, Webb RC. Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. Am J Physiol Regulatory Integrative Comp Physiol 2001;281:R944\u2013R950.","journal-title":"Am J Physiol Regulatory Integrative Comp Physiol"},{"key":"2349_CR31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0895-7061(03)00006-2","volume":"16","author":"R Sepehrdad","year":"2003","unstructured":"Sepehrdad R, Chander PN, Oruene A, Rosenfeld L, Levine S, Stier CT Jr. Amiloride reduces stroke and renal injury in stroke-prone hypertensive rats. Am J Hypertens 2003;16:312\u2013318.","journal-title":"Am J Hypertens"},{"key":"2349_CR32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.HYP.36.4.569","volume":"36","author":"M Sorooshian","year":"2000","unstructured":"Sorooshian M, Olson JL, Meyer TW. Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension. Hypertension 2000;36:569\u2013574.","journal-title":"Hypertension"},{"key":"2349_CR33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.HYP.0000049881.25304.73","volume":"41","author":"KA Griffin","year":"2003","unstructured":"Griffin KA, Abu-Amarah I, Picken M, Bidani AK. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension 2003;41:201\u2013206.","journal-title":"Hypertension"},{"key":"2349_CR34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","volume":"58","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Nakamura S, Ma L, et al. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 2000;58:1219\u20131227.","journal-title":"Kidney Int"},{"key":"2349_CR35","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","volume":"108","author":"EM Oestreicher","year":"2003","unstructured":"Oestreicher EM, Martinez-Vasquez D, Stone JR, et al. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-Nitro-L-arginine methyl ester-induced myocardial injury. Circulation 2003;108:2517\u20132523.","journal-title":"Circulation"},{"key":"2349_CR36","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","volume":"286","author":"I Juknevicius","year":"2004","unstructured":"Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH. Effect of aldosterone on renal transforming growth factor-\u03b2. Am J Physiol Renal Physiol 2004;286:F1059\u2013F1062.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2349_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1523-1755.2000.00148.x","volume":"58","author":"R Sharma","year":"2000","unstructured":"Sharma R, Khanna A, Sharma M, Savin VJ. Transforming growth factor-\u03b21 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals. Kidney Int 2000;58:131\u2013136.","journal-title":"Kidney Int"},{"key":"2349_CR38","unstructured":"Stier CT Jr, Zuckerman A, Harashima H, Chander PN. Antioxidants reduce aldosterone-induced renal vascular injury in stroke-prone spontaneously hypertensive rats. 18th International Society of Hypertension, Chicago, Il, 2000;5:S75."},{"key":"2349_CR39","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EAG, Polly ML, McMahon EG. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003;63:1791\u2013800.","journal-title":"Kidney Int"},{"key":"2349_CR40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","volume":"33","author":"R Rocha","year":"1999","unstructured":"Rocha R, Chander PN, Zuckerman A, Stier CT Jr. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999;33:232\u2013237.","journal-title":"Hypertension"},{"key":"2349_CR41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"EL Greene","year":"1996","unstructured":"Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996;98:1063\u20131068.","journal-title":"J Clin Invest"},{"key":"2349_CR42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","volume":"93","author":"GH Williams","year":"2004","unstructured":"Williams GH, Burgess E, Kolloch RE, et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol 2004;93:990\u2013996.","journal-title":"Am J Cardiol"},{"key":"2349_CR43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","volume":"345","author":"A Chrysostomou","year":"2001","unstructured":"Chrysostomou A, Becker G. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med 2001;345:925\u2013926.","journal-title":"N Engl J Med"},{"key":"2349_CR44","first-page":"1963","volume":"10","author":"RT Ganesvoort","year":"1995","unstructured":"Ganesvoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol Dial Transplant 1995;10:1963\u20131974.","journal-title":"Nephrol Dial Transplant"},{"key":"2349_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","volume":"66","author":"NK Hollenberg","year":"2004","unstructured":"Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int 2004;66:1\u20139.","journal-title":"Kidney Int"},{"key":"2349_CR46","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.V104814","volume":"10","author":"WR Fitzgibbon","year":"1999","unstructured":"Fitzgibbon WR, Greene EL, Grewal JS, et al. Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol 1999;10:814\u2013821.","journal-title":"J Am Soc Nephrol"},{"key":"2349_CR47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ki.1992.45","volume":"41","author":"ZY Quan","year":"1992","unstructured":"Quan ZY, Walser M, Hill GS. Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int 1992;41:326\u2013333.","journal-title":"Kidney Int"},{"key":"2349_CR48","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1097\/01.ASN.0000078960.15147.05","volume":"14","author":"PN Chander","year":"2003","unstructured":"Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, Stier CT Jr. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP. J Am Soc Nephrol 2003;14:1990\u20131997.","journal-title":"J Am Soc Nephrol"},{"key":"2349_CR49","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","volume":"141","author":"R Rocha","year":"2000","unstructured":"Rocha R, Stier CT Jr, Kifor I, et al. Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000;141:3871\u20133878.","journal-title":"Endocrinology"},{"key":"2349_CR50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000077396","volume":"24","author":"X Zhou","year":"2004","unstructured":"Zhou X, Ono H, Ono Y, Frohlich ED. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME\/SHR model. Am J Nephrol 2004;24:242\u2013249.","journal-title":"Am J Nephrol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-005-2349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-005-2349-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-005-2349-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-005-2349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T10:27:40Z","timestamp":1625999260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-005-2349-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1007\/s10741-005-2349-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}